ICAR-CMFRI commercialises its anti-obesity nutraceutical product ICAR Website dated 23rd May 2017

CMFRI, Library (2017) ICAR-CMFRI commercialises its anti-obesity nutraceutical product ICAR Website dated 23rd May 2017. Indian Council of Agricultural Research, New Delhi.

[img]
Preview
Text
ICAR-CMFRI commercialises its anti-obesity nutraceutical product _ Indian Council of Agricultural Research.pdf

Download (596kB) | Preview
Official URL: http://www.icar.org.in/en/node/12764

Abstract

ICAR-Central Marine Fisheries Research Institute, Kochi has commercialized its recently developed nutraceutical product for obesity and cholesterol named CadalminTM Antihypercholesterolemic extract (CadalminTM ACe). The ICAR-CMFRI gave the exclusive license to the VLCC, a leading Indian MNC in wellness and obesity management, for using the technology for commercial production and marketing of the product.

Item Type: Other
Uncontrolled Keywords: Newspaper; News; CMFRI in Media
Subjects: Library & Information Science
CMFRI News Clippings
Divisions: Library and Documentation Centre
Depositing User: Arun Surendran
Date Deposited: 26 May 2017 06:10
Last Modified: 26 May 2017 06:10
URI: http://eprints.cmfri.org.in/id/eprint/11849

Actions (login required)

View Item View Item